Overview

• President Donald Trump signed an executive order directing the development of policy recommendations to reduce the costs of in vitro fertilization (IVF) and protect access to the treatment.
• The executive order does not mandate immediate changes or specify whether cost reductions will be implemented through government funding, insurance mandates, or other means.
• Advocacy groups welcomed the move as a step forward but criticized the lack of concrete action or timelines for implementation.
• The order has drawn criticism from anti-abortion activists, who oppose IVF due to the creation and disposal of unused embryos, calling it inconsistent with pro-life values.
• The move aligns with the administration's pronatalist stance but leaves questions about its inclusivity, particularly regarding LGBTQ+ families and federal employee healthcare coverage.